362 related articles for article (PubMed ID: 29346317)
1. Liposomal TriCurin, A Synergistic Combination of Curcumin, Epicatechin Gallate and Resveratrol, Repolarizes Tumor-Associated Microglia/Macrophages, and Eliminates Glioblastoma (GBM) and GBM Stem Cells.
Mukherjee S; Baidoo JNE; Sampat S; Mancuso A; David L; Cohen LS; Zhou S; Banerjee P
Molecules; 2018 Jan; 23(1):. PubMed ID: 29346317
[TBL] [Abstract][Full Text] [Related]
2. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells.
Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P
J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669
[TBL] [Abstract][Full Text] [Related]
3. TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors.
Mukherjee S; Hussaini R; White R; Atwi D; Fried A; Sampat S; Piao L; Pan Q; Banerjee P
Cancer Immunol Immunother; 2018 May; 67(5):761-774. PubMed ID: 29453519
[TBL] [Abstract][Full Text] [Related]
4. Unique synergistic formulation of curcumin, epicatechin gallate and resveratrol, tricurin, suppresses HPV E6, eliminates HPV+ cancer cells, and inhibits tumor progression.
Mukherjee S; Debata PR; Hussaini R; Chatterjee K; Baidoo JNE; Sampat S; Szerszen A; Navarra JP; Fata J; Severinova E; Banerjee P; Castellanos MR
Oncotarget; 2017 Sep; 8(37):60904-60916. PubMed ID: 28977833
[TBL] [Abstract][Full Text] [Related]
5. Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma.
Mukherjee S; Baidoo J; Fried A; Atwi D; Dolai S; Boockvar J; Symons M; Ruggieri R; Raja K; Banerjee P
Int J Cancer; 2016 Dec; 139(12):2838-2849. PubMed ID: 27543754
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
7. TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma.
Piao L; Mukherjee S; Chang Q; Xie X; Li H; Castellanos MR; Banerjee P; Iqbal H; Ivancic R; Wang X; Teknos TN; Pan Q
Oncotarget; 2017 Sep; 8(36):60025-60035. PubMed ID: 28947951
[TBL] [Abstract][Full Text] [Related]
8. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.
Gras Navarro A; Kmiecik J; Leiss L; Zelkowski M; Engelsen A; Bruserud Ø; Zimmer J; Enger PØ; Chekenya M
J Immunol; 2014 Dec; 193(12):6192-206. PubMed ID: 25381437
[TBL] [Abstract][Full Text] [Related]
9. Enhancing Glioblastoma Immunotherapy with Integrated Chimeric Antigen Receptor T Cells through the Re-Education of Tumor-Associated Microglia and Macrophages.
Zhu N; Chen S; Jin Y; Wang M; Fang L; Xue L; Hua D; Zhang Z; Jia M; Hao M; Zhang C
ACS Nano; 2024 Apr; 18(17):11165-11182. PubMed ID: 38626338
[TBL] [Abstract][Full Text] [Related]
10. A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA.
Einbond LS; Zhou J; Wu HA; Mbazor E; Song G; Balick M; DeVoti JA; Redenti S; Castellanos MR
Br J Cancer; 2021 Mar; 124(5):901-913. PubMed ID: 33257842
[TBL] [Abstract][Full Text] [Related]
11. Using curcumin to turn the innate immune system against cancer.
Mukherjee S; Baidoo JNE; Fried A; Banerjee P
Biochem Pharmacol; 2020 Jun; 176():113824. PubMed ID: 31987852
[TBL] [Abstract][Full Text] [Related]
12. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.
Gersey ZC; Rodriguez GA; Barbarite E; Sanchez A; Walters WM; Ohaeto KC; Komotar RJ; Graham RM
BMC Cancer; 2017 Feb; 17(1):99. PubMed ID: 28160777
[TBL] [Abstract][Full Text] [Related]
13. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
Front Immunol; 2021; 12():637053. PubMed ID: 34108959
[TBL] [Abstract][Full Text] [Related]
14. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
[TBL] [Abstract][Full Text] [Related]
15. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.
Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X
J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
[TBL] [Abstract][Full Text] [Related]
17. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
[TBL] [Abstract][Full Text] [Related]
18. A New Perspective on Cancer Therapy: Changing the Treaded Path?
Baidoo JNE; Mukherjee S; Kashfi K; Banerjee P
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575998
[TBL] [Abstract][Full Text] [Related]
19. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.
Szulzewsky F; Pelz A; Feng X; Synowitz M; Markovic D; Langmann T; Holtman IR; Wang X; Eggen BJ; Boddeke HW; Hambardzumyan D; Wolf SA; Kettenmann H
PLoS One; 2015; 10(2):e0116644. PubMed ID: 25658639
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment.
Meisen WH; Wohleb ES; Jaime-Ramirez AC; Bolyard C; Yoo JY; Russell L; Hardcastle J; Dubin S; Muili K; Yu J; Caligiuri M; Godbout J; Kaur B
Clin Cancer Res; 2015 Jul; 21(14):3274-85. PubMed ID: 25829396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
